"Anthelmintics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents destructive to parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal.
| Descriptor ID |
D000871
|
| MeSH Number(s) |
D27.505.954.122.250.075
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Anthelmintics".
Below are MeSH descriptors whose meaning is more specific than "Anthelmintics".
This graph shows the total number of publications written about "Anthelmintics" by people in this website by year, and whether "Anthelmintics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 3 | 1 | 4 |
| 2021 | 2 | 1 | 3 |
| 2022 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anthelmintics" by people in Profiles.
-
Jacob J, Siraj MA, Steel A, Tan G, Jarvi S. Evaluation of the mechanism of action of albendazole on adult rat lungworm (Angiostrongyluscantonensis). Exp Parasitol. 2022 Nov; 242:108355.
-
Jacob J, Steel A, Kaluna L, Hess S, Leinbach I, Antaky C, Sugihara R, Hamilton L, Follett P, Howe K, Jacquier S, Wongwiwatthananukit S, Jarvi S. In vivo efficacy of pyrantel pamoate as a post-exposure prophylactic for rat lungworm (Angiostrongylus cantonensis). Int J Parasitol Drugs Drug Resist. 2022 08; 19:1-5.
-
Jacob J, Steel A, Lin Z, Berger F, Z?eller K, Jarvi S. Clinical Efficacy and Safety of Albendazole and Other Benzimidazole Anthelmintics for Rat Lungworm Disease (Neuroangiostrongyliasis): A Systematic Analysis of Clinical Reports and Animal Studies. Clin Infect Dis. 2022 04 09; 74(7):1293-1302.
-
Sutar Y, Fulton SR, Paul S, Altamirano S, Mhatre S, Saeed H, Patel P, Mallick S, Bhat R, Patravale VB, Chauhan H, Nielsen K, Date AA. Docusate-Based Ionic Liquids of Anthelmintic Benzimidazoles Show Improved Pharmaceutical Processability, Lipid Solubility, and in Vitro Activity against Cryptococcus neoformans. ACS Infect Dis. 2021 09 10; 7(9):2637-2649.
-
Adekiya TA, Kumar P, Kondiah PPD, Pillay V, Choonara YE. Synthesis and therapeutic delivery approaches for praziquantel: a patent review (2010-present). Expert Opin Ther Pat. 2021 Sep; 31(9):851-865.
-
Odani J, Sox E, Coleman W, Jha R, Malik R. First Documented Cases of Canine Neuroangiostrongyliasis Due to Angiostrongylus cantonensis in Hawaii. J Am Anim Hosp Assoc. 2021 Jan 01; 57(1):42-46.
-
Adekiya TA, Aruleba RT, Klein A, Fadaka AO. In silico inhibition of SGTP4 as a therapeutic target for the treatment of schistosomiasis. J Biomol Struct Dyn. 2022 05; 40(8):3697-3705.
-
Steel A, Jacob J, Klasner I, Howe K, Jacquier SH, Pitt WC, Hollingsworth R, Jarvi SI. In vitro comparison of treatments and commercially available solutions on mortality of Angiostrongylus cantonensis third-stage larvae. Parasitology. 2021 02; 148(2):212-220.
-
Jacob J, Tan G, Lange I, Saeed H, Date A, Jarvi S. In vitro efficacy of anthelmintics on Angiostrongylus cantonensis L3 larvae. Parasitology. 2021 02; 148(2):240-250.
-
Ansdell V, Kramer KJ, McMillan JK, Gosnell WL, Murphy GS, Meyer BC, Blalock EU, Yates J, Lteif L, Smith OA, Melish M. Guidelines for the diagnosis and treatment of neuroangiostrongyliasis: updated recommendations. Parasitology. 2021 02; 148(2):227-233.